Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.4%

3 terminated/withdrawn out of 127 trials

Success Rate

93.9%

+7.4% vs industry average

Late-Stage Pipeline

20%

25 trials in Phase 3/4

Results Transparency

7%

3 of 46 completed trials have results

Key Signals

12 recruiting3 with results

Enrollment Performance

Analytics

N/A
47(52.8%)
Phase 4
17(19.1%)
Phase 2
13(14.6%)
Phase 3
8(9.0%)
Phase 1
4(4.5%)
89Total
N/A(47)
Phase 4(17)
Phase 2(13)
Phase 3(8)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (127)

Showing 20 of 127 trials
NCT06330038Phase 4Recruiting

Anesthesia and Non-small Cell Lung Cancer Recurrence

Role: collaborator

NCT07505290Not ApplicableActive Not Recruiting

Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial for Children With Autism Spectrum Disorder

Role: collaborator

NCT06967441Recruiting

Respiratory Virus Infections in Acute Heart Failure

Role: collaborator

NCT05369182Active Not Recruiting

Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry)

Role: collaborator

NCT05221931Not ApplicableActive Not Recruiting

Drug-Coated Balloon in Patients With High Bleeding Risk

Role: collaborator

NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT06086665Completed

The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer

Role: collaborator

NCT07380867Not ApplicableEnrolling By Invitation

Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.

Role: lead

NCT07345026Not ApplicableNot Yet Recruiting

Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients

Role: lead

NCT07240844Phase 4Not Yet Recruiting

Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy

Role: lead

NCT04942886Not ApplicableEnrolling By Invitation

Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation

Role: lead

NCT04921189Phase 2Completed

Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors

Role: collaborator

NCT06099366Phase 2Recruiting

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Role: collaborator

NCT06257394Phase 2Recruiting

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

Role: collaborator

NCT05827549Phase 2Recruiting

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

Role: collaborator

NCT05639309Completed

Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus

Role: lead

NCT06218485Not ApplicableRecruiting

FFR Versus IVUS with Angiography-Derived FFR for Clinical Outcomes in Patients with Coronary Artery Disease

Role: collaborator

NCT04696042Completed

Asian Investigation of Lanreotide Autogel® in the Management of GEP-NETs

Role: collaborator

NCT06769087Not ApplicableEnrolling By Invitation

Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery

Role: lead

NCT05770687Recruiting

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

Role: collaborator